Fundz
An acquisition means integration work is about to be scoped. Fundz scores the company against what you sell, and says why it matched.See it live →

Gland Pharma to acquire Gland Pharma USA for $501,208

RECENTLY ACQUIREDSep 14, 2026about 2 hours ago

Acquiring Company

Gland Pharma USA

Acquired Company

Gland Pharma USA

HyderabadHyderabadBiotechnologyPharmaceuticalBiotechnologyPharmaceutical

Description

Gland Pharma has approved the acquisition of 100% of Gland Pharma USA Inc. from its parent company for US$ 501,208. This move aims to streamline Gland Pharma’s structure by removing multiple layers of ownership. The acquisition will make Gland Pharma USA a direct wholly owned subsidiary of Gland Pharma. The completion of the transaction is expected by October 31, 2026.

Company Information

Company

Gland Pharma USA

Location

Hyderabad, Telangana, India

About

Gland Pharma USA Inc. is a wholly owned subsidiary of Gland Pharma. It was incorporated on March 7, 2022, and focuses on the marketing and distribution of pharmaceutical products in the United States. The entity operates within the pharmaceutical industry. It is set to operate directly under Gland Pharma after the acquisition.

Don't miss Gland Pharma USA's next move

Get an email the moment Gland Pharma USA makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Wriddhee
Senior decision-maker at this company
••••••••@••••••••

See Wriddhee's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Gland Pharma USA's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Gland Pharma USA?

Gland Pharma USA was acquired by Gland Pharma USA, based in Hyderabad. The deal was reported on September 14, 2026. Gland Pharma USA Inc. is a wholly owned subsidiary of Gland Pharma. It was incorporated on March 7, 2022, and focuses on the marketing and distribution of pharmaceutical products in the United States. Gland Pharma USA is privately held and operates in Biotechnology.

When did Gland Pharma USA acquire Gland Pharma USA?

Gland Pharma USA's acquisition of Gland Pharma USA was reported on September 14, 2026. Gland Pharma has approved the acquisition of 100% of Gland Pharma USA Inc. from its parent company for US$ 501,208. This move aims to streamline Gland Pharma’s structure by removing multiple layers of ownership. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Gland Pharma USA do?

Gland Pharma USA Inc. is a wholly owned subsidiary of Gland Pharma. It was incorporated on March 7, 2022, and focuses on the marketing and distribution of pharmaceutical products in the United States. The entity operates within the pharmaceutical industry. It is privately held, operating in Biotechnology, and is based in Hyderabad.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.